Drug Shortage Report for PRIORIX-TETRA

Last updated on 2019-01-18 History
Report ID 69657
Drug Identification Number 02297884
Brand name PRIORIX-TETRA
Common or Proper name Combined measles, mumps, rubella and varicella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size 10's
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-13
Estimated end date 2019-02-04
Actual end date 2019-01-17
Shortage status Resolved
Updated date 2019-01-18
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-01-18 French Compare
v4 2019-01-18 English Compare
v3 2018-12-14 French Compare
v2 2018-12-14 French Compare
v1 2018-12-14 English Compare